Speaker illustration

Doctor Brian Stauffer

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

Elamipretide, a cardiolipin-targeting peptide, decreases mitochondrial oxidant stress in the failing human heart

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Pathophysiology

Session: Rapid Fire 5 - Diagnosis - Pathophysiology - Prognosis

Thumbnail

Elamipretide improves mitochondrial activity in the failing human heart.

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cell Signalling

Session: A mitochondrial approach to heart failure

Thumbnail

MTP-131, a cardiolipin-targeting peptide, improves mitochondrial activity in the failing human heart

Event: HEART FAILURE 2016

Topic: Chronic Ischaemic heart disease

Session: Rapid Fire 3 - Chronic heart failure management

Thumbnail

Elamipretide improves mitochondrial activity in the failing human heart.

Event: HEART FAILURE 2016

Topic: Cell Signalling

Session: Targeting mitochondria to improve outcomes in heart failure

Thumbnail

ESC 365 is supported by

logo Novo Nordisk